These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26512619)

  • 1. Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment.
    Li M; Fan Y; Li Q; Zhang P; Yuan P; Ma F; Wang J; Luo Y; Cai R; Chen S; Li Q; Xu B
    Medicine (Baltimore); 2015 Oct; 94(43):e1928. PubMed ID: 26512619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and toxicity of vinorelbine (NVB)-based regimens in patients with metastatic triple negative breast cancer (mTNBC) pretreated with anthracyclines and taxanes].
    Du F; Yuan P; Luo Y; Wang J; Ma F; Cai R; Fan Y; Li Q; Zhang P; Xu B
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):788-92. PubMed ID: 26813602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Vinorelbine Plus Cisplatin vs. Gemcitabine Plus Cisplatin for Treatment of Metastatic Triple-Negative Breast Cancer After Failure with Anthracyclines and Taxanes.
    Wang J; Zheng R; Wang Z; Yang Y; Wang M; Zou W
    Med Sci Monit; 2017 Sep; 23():4657-4664. PubMed ID: 28957036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer.
    Zhang J; Wang L; Wang Z; Hu X; Wang B; Cao J; Lv F; Zhen C; Zhang S; Shao Z
    Cancer Biol Ther; 2015; 16(2):225-32. PubMed ID: 25648299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment.
    Vassilomanolakis M; Koumakis G; Demiri M; Missitzis J; Barbounis V; Efremidis AP
    Cancer Invest; 2003; 21(4):497-504. PubMed ID: 14533438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.
    Zelek L; Barthier S; Riofrio M; Fizazi K; Rixe O; Delord JP; Le Cesne A; Spielmann M
    Cancer; 2001 Nov; 92(9):2267-72. PubMed ID: 11745280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines.
    Vassilomanolakis M; Koumakis G; Barbounis V; Demiri M; Pateras H; Efremidis AP
    Ann Oncol; 2000 Sep; 11(9):1155-60. PubMed ID: 11061611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer.
    Lee J; Kim HH; Ro SM; Yang JH
    PLoS One; 2017; 12(2):e0171605. PubMed ID: 28234911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential therapy with capecitabine followed by vinorelbine/cisplatin in patients with anthracycline/taxane-refractory metastatic breast cancer.
    Lin PC; Wang WS; Yang MH; Yen CC; Chao TC; Hsiao LT; Chen PM
    J Chin Med Assoc; 2006 Jul; 69(7):304-9. PubMed ID: 16903643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of vinorelbine monotherapy in anthracycline and taxane pre-treated metastatic breast cancer.
    Seo HY; Lee HJ; Woo OH; Park KH; Woo SU; Yang DS; Kim AR; Lee JB; Lee ES; Kim YH; Kim JS; Seo JH
    Invest New Drugs; 2011 Apr; 29(2):360-5. PubMed ID: 19943080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
    Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy.
    Palomo AG; Glogowska I; Sommer H; Malamos N; Kilar E; Vega JM; Torrecillas L; Delozier T; Ettl J; Finek J
    Anticancer Res; 2012 Oct; 32(10):4539-45. PubMed ID: 23060583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects and toxicity of neoadjuvant chemotherapy with vinorelbine and cisplatin in treatment of operable breast cancer previously non-responsive to anthracyclines and taxanes-containing regimen: analysis of 19 cases].
    Xu L; Ye JM; Zhao JX; Duan XN; Liu YH
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):683-5. PubMed ID: 19595063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer.
    Rodler ET; Kurland BF; Griffin M; Gralow JR; Porter P; Yeh RF; Gadi VK; Guenthoer J; Beumer JH; Korde L; Strychor S; Kiesel BF; Linden HM; Thompson JA; Swisher E; Chai X; Shepherd S; Giranda V; Specht JM
    Clin Cancer Res; 2016 Jun; 22(12):2855-64. PubMed ID: 26801247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
    Fan Y; Xu B; Yuan P; Wang J; Ma F; Li Q; Zhang P; Li Q; Cai R
    Chemotherapy; 2010; 56(4):340-7. PubMed ID: 20720418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine and infusional 5-fluorouracil in anthracycline and taxane pre-treated metastatic breast cancer.
    Stuart NS; McIllmurray MB; Bishop JL; Johnston SR; Price CG; O'Reilly SM; Joffe JK; Neave F; Whipp EC
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):152-6. PubMed ID: 18083354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience.
    Decatris MP; Sundar S; O'Byrne KJ
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):249-57. PubMed ID: 15997920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: a multicenter phase II study.
    Makrantonakis P; Ziotopoulos P; Agelidou A; Polyzos A; Ziras A; Chandrinos V; Vossos A; Kalykaki A; Androulakis N; Geroyianni A; Georgoulias V;
    Lung Cancer; 2006 Jul; 53(1):85-90. PubMed ID: 16720058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world data on the efficacy and safety of weekly oral vinorelbine in breast cancer patients previously treated with anthracycline or taxane-based regimens.
    Blancas I; Aguirre E; Morales S; Gonzálvez ML; Servitja S; Díaz N; Del Barco S; Barnadas A; Margelí M; García Carbonero I; Llombart A
    Clin Transl Oncol; 2019 Apr; 21(4):459-466. PubMed ID: 30293232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.